Texas to launch its own ibogaine trials after failing to secure pharma partner
Texas officials on Tuesday announced that the state will launch its own research program into the psychedelic drug ibogaine after failing to secure a partnership with a private company, allocating $50 million in state funds to support the effort and advance development toward potential federal approval.